Fucicort

Fucicort

betamethasone + fusidic acid

Manufacturer:

LEO Pharma

Distributor:

DKSH
Full Prescribing Info
Contents
Fusidic acid, betamethasone valerate.
Description
Each gram contains: Fusidic acid 20 mg, Betamethasone as valerate 1 mg.
Preserved with chlorocresol.
Action
Pharmacology: Properties: Fucicort cream combines the potent topical antibacterial action of fusidic acid with the anti-inflammatory and antipruritic effects of betamethasone. Betamethasone valerate is a topical steroid with rapid effect in inflammatory dermatoses. Even refractory conditions can often be treated successfully. When applied topically, fusidic acid is effective against Staphylococci, Streptococci, Corynebacteria, Neisseria and certain Clostridia and Bacteroides. The antibacterial activity of fusidic acid is not diminished in the presence of betamethasone.
Indications/Uses
Fucicort cream is indicated in inflammatory dermatoses where bacterial infection is present or likely to occur. Inflammatory dermatoses include atopic eczema, discoid eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus.
Dosage/Direction for Use
Uncovered lesions: Apply 2-3 daily applications.
Covered lesions: Less frequent applications may be adequate.
Overdosage
Topically applied corticosteroids can be absorbed in sufficient amounts of produce systemic effects (see Adverse Reactions).
Contraindications
Topical corticosteroids are contra-indicated in viral, tuberculous and fungal skin infections, perioral dermatitis, acne rosacea and ulcerative condition.
Hypersensitivity to any component.
Special Precautions
Long-term continuous therapy should be avoided, particularly in the face, on flexures, and intertrigenous areas, and in infants and children. Topical steroids should not be used extensively in pregnancy - fetal abnormalities have been seen in animals due to systemic absorption.
Adverse Reactions
Hypersensitivity has rarely been encountered. As with other topical corticosteroids, prolonged and intensive treatment may cause local atrophic changes of the skin, such as striae, thinning and dilatation of the superficial blood vessels, particularly when occlusive dressing is used or when skin folds are involved. Systemic absorption, sufficient to produce hypercorticism/adrenal suppression, can occur with prolonged or extensive use, especially when used under occlusion/napkin.
Infants and children are particularly at risk.
Caution should be exercised if a topical steroid is used near the eye. Glaucoma might be the result if the preparation enters the eye.
Drug Interactions
No known drug interaction to date.
Caution For Usage
Incompatibilities: No known incompatibilities to date.
Storage
Do not store above 30°C.
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Presentation/Packing
Cream 5 g, 15 g.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in